These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 30639415)

  • 1. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
    Yang ZQ; Liu YJ; Zhou XL
    Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
    Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
    J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
    Li C; Zeng X; Yu H; Gu Y; Zhang W
    World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
    Chang X; Yang MF; Fan W; Wang LS; Yao J; Li ZS; Li DF
    J Comput Biol; 2020 Nov; 27(11):1595-1609. PubMed ID: 32216644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
    Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
    EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.
    Lu Y; Li C; Chen H; Zhong W
    Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Deng Y; Ma H; Hao J; Xie Q; Zhao R
    Biomed Res Int; 2020; 2020():8604340. PubMed ID: 32420375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis.
    Ding W; Wang Y; Ma Y; Lin L; Li M
    Dis Markers; 2022; 2022():3839480. PubMed ID: 36061357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling.
    Dang C; Bian Q; Wang F; Wang H; Liang Z
    Sci Rep; 2024 Jan; 14(1):2116. PubMed ID: 38267509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes.
    Zheng B; Peng J; Mollayup A; Bakri A; Guo L; Zheng J; Xu H
    Mol Med Rep; 2018 Jan; 17(1):216-224. PubMed ID: 29115420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.
    Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
    DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.
    Ma W; Li T; Wu S; Li J; Wang X; Li H
    Cancer Biol Ther; 2019; 20(6):787-798. PubMed ID: 30712446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
    Liu S; Cai Y; Changyong E; Sheng J; Zhang X
    Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.